LINC01210

Across TCGA pan-cancer cohorts, LINC01210 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated LINC01210 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher LINC01210 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC01210 expression acts as an unfavorable survival marker, although some lineages such as STAD and OV show a favorable association.

UCS, ACC, and STAD are the cancer types where LINC01210 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Tertile	IV	0.132	0.718	.002	108	view →
ACC	DFS	Tertile	All	0.046	0.753	<.001	108	view →
STAD	DFS	Median	IV	0.566	0.157	.003	64	view →
OV	OS	Tertile	IV	1.000	0.564	.003	36	view →
CESC	DFS	Tertile	IV	0.332	0.567	.012	36	view →
SKCM	DFS	Tertile	III,IV	0.272	0.669	<.001	33	view →
LGG	DFS	Tertile	All	0.626	0.843	<.001	33	view →
LUSC	OS	Tertile	III,IV	0.176	0.777	.002	30	view →
KIRC	OS	Tertile	All	0.512	0.654	.014	24	view →
MESO	OS	Tertile	IV	0.155	0.624	.004	18	view →
KIRP	OS	Tertile	All	0.248	0.720	.003	15	view →
SARC	OS	Tertile	All	0.324	0.617	.003	15	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

LINC01210–UCS (DFS)

Open the UCS breakdown →